Trading name OTCPK:MDABY Website www.meda.se Founded 1995 | Number of employees 5,202 (2014) Headquarters Sweden | |
 | ||
Revenue >kr 15,000,000,000 (2014) Stock price MDABY (OTCMKTS) US$ 18.00 0.00 (0.00%)15 Mar, 4:00 PM GMT-4 - Disclaimer CEO Jorg-Thomas Dierks (1 Oct 2013–) Subsidiaries Rottapharm, Meda Valeant Pharma Canada Inc | ||
Meda AB is an international specialty pharmaceutical company, headquartered in Solna, Sweden. Sales at the end of 2014 amounted to more than kr 15,000,000,000, making it the 48th largest pharmaceutical company in the world. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are sold in more than 150 countries.
Meda has been listed since 1995 on the Stockholm stock market and is currently part of the Nasdaq OMX Nordic 120 index, though not of the OMX Nordic 40.
Mergers, acquisitions and divestments
In 2014, Meda acquired the Italian firm RottaPharm Madaus in order to add consumer health products to their portfolio. Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.
References
Meda AB Wikipedia(Text) CC BY-SA